Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma [Phase 1, Phase 2]
Genmab-sponsored first-in-human trial in relapsed/refractory B-cell lymphomas spans Phase 1/2 and is currently active/not recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP [Phase 2]
Phase 2 trial evaluating rituximab with glofitamab and polatuzumab vedotin for previously untreated aggressive B-cell lymphoma ineligible fo…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL) [Phase 1, Phase 2]
Clinical trial update announcing a Phase 1/2 study of epcoritamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) [Phase 1, Phase 2]
Clinical trial update on a phase 1/2 study evaluating safety and efficacy of epcoritamab combinations in adults with diffuse large B-cell ly…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma [Phase 2]
A Phase 2 clinical trial update assessing safety and efficacy of epcoritamab combined with GDP salvage chemotherapy for relapsed/refractory …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma [NA]
A clinical trial evaluating MRD-adapted low-dose radiation therapy during frontline chemoimmunotherapy for diffuse large B-cell lymphoma is …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of CAR-T Therapy in Older Patients
A clinical trial update describing a CAR-T therapy study enrolling older adults with B-cell lymphomas and multiple myeloma, currently recrui…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 3]
A Phase III study comparing glofitamab plus gemcitabine and oxaliplatin versus rituximab plus gemcitabine and oxaliplatin in relapsed/refrac…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping [Phase 3]
Phase 3 trial comparing C Pola R-CHP+X versus CR-CHOP for previously untreated double-expressor diffuse large B-cell lymphoma under genotypi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym [Phase 2]
Phase 2 trial evaluating tafasitamab plus lenalidomide as first salvage therapy for residual large B-cell lymphoma is currently recruiting (…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]
Phase 1 trial evaluating an anti-CD30 bispecific antibody (AATC) in relapsed/refractory CD30-positive hematologic malignancies; currently re…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]
A Phase 1 study of CLIC-2201 for relapsed/refractory B-cell malignancies is currently recruiting. The conditions covered include various B-c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
This entry describes an observational study of Glofitamab in Chinese adults with second-line Diffuse Large B-Cell Lymphoma and notes that th…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
Clinical trial update for Allo-QuadCAR01-T, an allogeneic CD19/CD20 CAR-T, in relapsed or refractory B-cell malignancies, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse [Phase 2]
Phase 2 trial from Fudan University evaluating R-CDOP with intrathecal methotrexate for diffuse large B-cell lymphoma patients at high risk …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 1]
This Phase 1 clinical trial update describes evaluating the safety and preliminary efficacy of a triplet regimen (glofitamab, gemcitabine, a…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients [Phase 3]
Phase 3 clinical trial update evaluating Tafasitamab plus Lenalidomide in combination with R-CHOP versus R-CHOP alone for newly diagnosed hi…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers [Phase 1]
Phase 1 clinical trial update for PF-08046032 in people with advanced cancers; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Low Dose Epcoritamab Plus GemOx in R/R DLBCL [Phase 2]
A Phase 2 clinical trial is testing low-dose epcoritamab in combination with GemOx (gemcitabine and oxaliplatin) for relapsed/refractory dif…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL [Phase 3]
A Phase III clinical trial evaluating HMPL-760 plus R-GemOx versus placebo plus R-GemOx for relapsed/refractory diffuse large B-cell lymphom…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update for SHB-02-CD19, a novel CD19-directed CAR-T therapy, in CD19-expressing B-cell malignancies; recruitment not yet sta…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating memory-enriched T cells following stem cell transplantation for recurrent B-cell non-Hodgkin lymphomas; the study i…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy [Phase 2]
This clinical trial update indicates that Itacitinib is being studied as pre-modulation therapy in patients with diffuse large B-cell lympho…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant [Phase 2]
This Phase 2 clinical trial from Washington University School of Medicine is evaluating thiotepa-based autologous stem cell transplantation …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL [Phase 2]
Phase 2 single-arm trial evaluating ablative bridging irradiation before CD19 CAR-T therapy in high-risk relapsed/refractory large B-cell ly…